Skip to main content

Day: July 24, 2020

Alingsås Tingsrätt fastställer ackord enligt förslag

Alingsås Tingsrätt har idag meddelat beslut från ackordsförhandling och fastställer ackordsförslaget. Samtidigt beslutar tingsrätten att förlänga rekonstruktionen till den 21 oktober.Det ackordsförslag som Clean Motion AB framställde den 18 juni har fastställts av tingsrätten. Beslutet vinner laga kraft den 14 augusti. Tingsrätten har samtidigt fattat beslut om att förlänga rekonstruktionen till den 21 oktober.Det offentliga ackordet innebär att fordringar betalas fullt upp till 2 000 kr och med 25% på belopp överstigande 2 000 kr. Alternativt erbjuds deltagande I kvittningsemission till en kurs på 1,05 kr per aktie.Ackordsförslaget och bolagets framtida verksamhet enligt rekonstruktionsplanen finansieras genom ett tillskott av eget kapital omfattande 15 000 000 kr genom riktad emission av aktier och/eller konvertibler till Interest Group...

Continue reading

Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend

RICHMOND, Va., July 24, 2020 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Atlantic Union Bankshares Corporation (the “Company”) has declared a quarterly dividend of $0.25 per share of common stock.  The common stock dividend amount is the same as that paid in the prior quarter and the third quarter of 2019.Based on the Company’s common stock closing price of $23.79 on July 23, 2020, the dividend yield is approximately 4.2%.  The common stock dividend is payable on August 21, 2020 to common shareholders of record as of August 7, 2020.The Board also declared a quarterly dividend on the outstanding shares of its 6.875% Perpetual Non-Cumulative Preferred Stock, Series A (the “Series A preferred stock”). The Series A preferred stock is represented by depositary shares, each representing a 1/400th ownership interest in a...

Continue reading

Harsco Rail Signs Its First-Ever Contract With Hungarian Railways

US $10.3 million order is first grinder contract for MÁV FKG Kft-t, which manages all maintenance and renovation of the national railway networkHungary joins the UK, Germany, Sweden and Italy, all of which have been using Harsco Rail grinders for yearsCAMP HILL, Pa., July 24, 2020 (GLOBE NEWSWIRE) — Harsco Corporation (NYSE: HSC) announced today that its Rail division has signed a $10.3 million contract with MÁV FKG Kft-t to provide it with an EU 20-stone rail grinder. This is the first-ever grinder order by Hungarian Railways, which joins a long list of countries that have been using the efficient and reliable Harsco Rail grinders for years.Harsco Rail’s 20 stone grinder (RGH20C2), which removes surface defects on rails and re-profiles the rail head on both rails, is one of the most technologically advanced grinders working today....

Continue reading

Skyharbour Partner Company Azincourt Announces 2020 Geophysical Target Generation Program at the East Preston Uranium Project

VANCOUVER, British Columbia, July 24, 2020 (GLOBE NEWSWIRE) — Skyharbour  Resources Ltd. (TSX-V:SYH)  (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce that its partner company Azincourt Energy Corp. (“Azincourt”) has announced a Summer Geophysical Target Generation Program at East Preston Uranium Project located 50 km southeast of Patterson Lake in the Western Athabasca Basin, northern Saskatchewan, Canada. Preston Uranium Project Map:http://skyharbourltd.com/_resources/maps/SYH-Patterson-Lake.pdfSkyharbour and Dixie Gold Inc. (“Dixie Gold”) entered into an Option Agreement (the “Agreement”) with Azincourt whereby Azincourt has an earn-in option to acquire a 70% working interest in a portion of the Preston Uranium Project known as the East Preston Property. Under the Agreement, Azincourt has issued common shares...

Continue reading

Gulfport Energy Corporation Schedules Second Quarter 2020 Financial and Operational Results Conference Call

OKLAHOMA CITY, July 24, 2020 (GLOBE NEWSWIRE) — Gulfport Energy Corporation (NASDAQ: GPOR) (“Gulfport” or the “Company”) announced the date and time of its conference call to discuss financial and operational results for the second quarter of 2020.Gulfport will hold its second quarter 2020 earnings conference call on Wednesday, August 5, 2020 at 9:00 a.m. Central Time. Gulfport’s second quarter 2020 earnings are scheduled to be released after the market close on Tuesday, August 4, 2020.Interested parties may listen to the call via Gulfport’s website at www.gulfportenergy.com or by calling toll-free at 866-373-3408 or 412-902-1039 for international callers. A replay of the call will be available for two weeks at 877-660-6853 or 201-612-7415 for international callers. The replay passcode is 13707137. The webcast will also be...

Continue reading

UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced it will report financial results for the second quarter ended June 30, 2020, on Friday, July 31, 2020 after NASDAQ market close.UNITY will not conduct a conference call in conjunction with the financial results press release.About UNITYUNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby provide transformative benefit in age-related diseases, such as osteoarthritis, eye diseases, neurological diseases and pulmonary diseases. More information is available...

Continue reading

Arca Continental Reports Revenue Growth of 2.3% With EBITDA Up 1.8% in 2Q20

MONTERREY, Mexico, July 24, 2020 (GLOBE NEWSWIRE) — Arca Continental, S.A.B. de C.V. (BMV: AC*) (“Arca Continental” or “AC”), the second-largest Coca-Cola bottler in Latin America, announced its results for the second quarter and first half of 2020 (“2Q20” and “6M20”).Table 1: Financial Highlights 2Q20 HIGHLIGHTSNet Sales reached Ps. 42,945 million, up 2.3% when compared to 2Q19.EBITDA totaled Ps. 8,235 million, a margin of 19.2%, representing an increase of 1.8%.Net Income declined 17.1% to Ps. 2,335 million for a margin of 5.4%.6M20 HIGHLIGHTSNet Sales increased 3.7% to Ps. 81,837 million.EBITDA totaled Ps. 14,872 million, 3.5% higher than 2Q19 for a margin of 18.2%.Net Income grew 10.9% to Ps. 5,013 million for a margin of 6.1%.COMMENTS FROM THE CHIEF EXECUTIVE OFFICER“In one of the most challenging quarters in our company’s...

Continue reading

GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA®  (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE  RHEUMATOID  ARTHRITIS

— Clinical Development Program of Filgotinib Demonstrated Durable Efficacy Balanced with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks —Foster City, Calif., and Mechelen, Belgium, July 24 2020, 14:10 CET; regulated information – Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) announced today the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Jyseleca® (filgotinib 200 mg and 100 mg tablets), an investigational, once-daily, oral, selective JAK1 inhibitor for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs). The CHMP positive opinion is a scientific recommendation...

Continue reading

GILEAD  EN  GALAPAGOS  KONDIGEN  POSITIEVE  EUROPESE CHMP  OPINIE AAN  VOOR  JYSELECA® (FILGOTINIB)  VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE  REUMATOïDE  ARTRITIS

— Klinisch ontwikkelingsprogramma van filgotinib laat duurzame werkzaamheid en een consistent veiligheidsprofiel zien bij reumatoïde artritis tot 52 weken —Foster City, Calif., & Mechelen, België, 24 juli 2020, 14:10 CET; gereglementeerde informatie – Gilead Sciences, Inc. (Nasdaq: GILD) en Galapagos NV (Euronext & Nasdaq: GLPG) kondigen vandaag aan dat de Commissie voor geneesmiddelen voor menselijk gebruik (CHMP) van het Europees Geneesmiddelenagentschap (EMA) een positief advies heeft uitgebracht voor Jyseleca® (filgotinib 200 mg en 100 mg tabletten), een experimentele eenmaal daagse, orale, selectieve JAK1 remmer voor de behandeling van volwassenen met matige tot ernstige reumatoïde artritis (RA, in de volksmond reuma) die eerder onvoldoende hebben gereageerd  op of intolerant zijn voor ziekte-modificerende anti-reumatische ...

Continue reading

Grupo Aeroportuario del Pacifico Announces Results for the Second Quarter of 2020

GUADALAJARA, Mexico, July 24, 2020 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reported its consolidated results for the second quarter ended June 30, 2020 (2Q20). Figures are unaudited and have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).COVID-19 ImpactDuring the second quarter of the year, the COVID-19 pandemic considerably affected the Company’s results, mainly with the decrease in international and domestic passenger traffic. Even though the Government of Mexico did not issue any flight restrictions during the quarter, during the months of April and May, activity for certain economic sectors did suffer restrictions. Other sectors, deemed essential,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.